{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:48:24Z","timestamp":1780375704002,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.rce.2014.05.028","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T11:46:37Z","timestamp":1404992797000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Control gluc\u00e9mico en pacientes con diabetes mellitus tipo 2 en Espa\u00f1a"],"prefix":"10.1016","volume":"214","author":[{"given":"A.","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Mediavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mi\u00f1ambres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gonz\u00e1lez-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2014.05.028_bib0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","article-title":"Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study","volume":"55","author":"Soriguer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.rce.2014.05.028_bib0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0213-9111(02)71973-0","article-title":"El coste de la diabetes tipo 2 en Espana. El estudio CODE-2","volume":"16","author":"Mata","year":"2002","journal-title":"Gac Sanit"},{"issue":"Suppl 3","key":"10.1016\/j.rce.2014.05.028_bib0015","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.2337\/diabetes.53.suppl_3.S39","article-title":"Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis","volume":"53","author":"Gaede","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.rce.2014.05.028_bib0020","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group."},{"key":"10.1016\/j.rce.2014.05.028_bib0025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.05.028_bib0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.medcli.2009.06.033","article-title":"Evolucion de los indicadores de calidad asistencial al diabetico tipo 2 en atenci\u00f3n primaria (1996-2007). Programa de mejora continua de calidad de la Red de Grupos de Estudio de la Diabetes en Atenci\u00f3n Primaria de la Salud","volume":"135","author":"Franch Nadal","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rce.2014.05.028_bib0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2337\/dc11-1679","article-title":"Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain)","volume":"35","author":"Vinagre","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.medcli.2011.06.026","article-title":"Relaci\u00f3n del grado de control gluc\u00e9mico con las caracter\u00edsticas de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2","volume":"138","author":"Perez","year":"2012","journal-title":"Estudio DIABES Med Clin (Barc)"},{"key":"10.1016\/j.rce.2014.05.028_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3810\/pgm.2013.05.2664","article-title":"Accuracy and clinical utility of a point-of-care HbA1c testing device","volume":"125","author":"Knaebel","year":"2013","journal-title":"Postgrad Med"},{"key":"10.1016\/j.rce.2014.05.028_bib0050","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.endonu.2010.07.005","article-title":"Recomendaciones para el tratamiento farmacol\u00f3gico de la hiperglucemia en la diabetes tipo 2","volume":"58","author":"Menendez Torre","year":"2011","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.rce.2014.05.028_bib0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-154-8-201104190-00007","article-title":"Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials","volume":"154","author":"Ismail-Beigi","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rce.2014.05.028_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"Skyler","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0070","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1742-1241.2007.01367.x","article-title":"Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain","volume":"61","author":"Orozco-Beltran","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rce.2014.05.028_bib0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0014-2565(04)71388-0","article-title":"Perfil de los pacientes con diabetes mellitus tipo 2, en la Atencion Primaria espa\u00f1ola","volume":"204","author":"Benito Lopez","year":"2004","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2014.05.028_bib0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1575-0922(09)71406-8","article-title":"Estudio epidemiol\u00f3gico del perfil cl\u00ednico y control gluc\u00e9mico del paciente diab\u00e9tico atendido en centros de atenci\u00f3n primaria en Espana (estudio EPIDIAP)","volume":"56","author":"De Pablos Velasco","year":"2009","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.rce.2014.05.028_bib0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/dc11-2344","article-title":"Public health implications of recommendations to individualize glycemic targets in adults with diabetes","volume":"36","author":"Laiteerapong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2008-1073127","article-title":"Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study","volume":"117","author":"Huppertz","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.rce.2014.05.028_bib0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2337\/dc07-1572","article-title":"Is glycemic control improving in U.S. adults?","volume":"31","author":"Hoerger","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0100","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.rce.2014.05.028_bib0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2458-5-36","article-title":"Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study","volume":"5","author":"Benoit","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.rce.2014.05.028_bib0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.420","article-title":"Management of type 2 diabetes in the primary care setting: a practice-based research network study","volume":"4","author":"Spann","year":"2006","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.rce.2014.05.028_bib0115","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/oby.2008.12","article-title":"Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes","volume":"16","author":"Blaha","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.rce.2014.05.028_bib0120","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/diacare.28.8.2019","article-title":"Metabolic syndrome in type 1 diabetes: Association with diabetic nephropathy and glycemic control (the Finn Diane study)","volume":"28","author":"Thorn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0125","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(89)92804-3","article-title":"Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes","volume":"333","author":"Saad","year":"1989","journal-title":"The Lancet"},{"key":"10.1016\/j.rce.2014.05.028_bib0130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1471-2458-13-602","article-title":"Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables","volume":"13","author":"Ji","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.rce.2014.05.028_bib0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.medcli.2011.07.023","article-title":"Inercia y cumplimiento terap\u00e9utico en pacientes con diabetes mellitus tipo 2 en atenci\u00f3n primaria","volume":"138","author":"Lopez-Simarro","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rce.2014.05.028_bib0140","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/diacare.27.7.1535","article-title":"The burden of treatment failure in type 2 diabetes","volume":"27","author":"Brown","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.endonu.2012.11.009","article-title":"Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens","volume":"60","author":"Vinagre","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.rce.2014.05.028_bib0150","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMoa075392","article-title":"Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes","volume":"357","author":"Holman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.05.028_bib0155","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMoa0905479","article-title":"Three-year efficacy of complex insulin regimens in type 2 diabetes","volume":"361","author":"Holman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.05.028_bib0160","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diab.43.11.1378","article-title":"Banting lecture hypoglycemia: the limiting factor in the management of IDDM","volume":"43","author":"Cryer","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.rce.2014.05.028_bib0165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1016\/j.rce.2014.05.028_bib0170","first-page":"S11","article-title":"Standards of medical care in diabetes\u20132013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2014.05.028_bib0175","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2010.405","article-title":"Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes","volume":"303","author":"Phung","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.rce.2014.05.028_bib0180","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1463-1326.2012.01606.x","article-title":"Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis","volume":"14","author":"Liu","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rce.2014.05.028_bib0185","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-007-0599-y","article-title":"Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration","volume":"50","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.rce.2014.05.028_bib0190","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-5491.2005.01501.x","article-title":"Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study","volume":"22","author":"Donnelly","year":"2005","journal-title":"Diabet Med"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256514002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256514002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T19:32:43Z","timestamp":1649619163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256514002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0014256514002562"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2014.05.028","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control gluc\u00e9mico en pacientes con diabetes mellitus tipo 2 en Espa\u00f1a","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2014.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}